News

Morning sickness linked to lower risk of pregnancy loss

View on the News

Valuable contribution to the literature

This study’s contribution to the existing literature is valuable because investigators were able to compare nausea and vomiting among women who experienced an early pregnancy loss with those whose pregnancies continued. Furthermore, by collecting daily urine samples, it was possible to identify all pregnancies very early in gestation and thus definitively quantify the losses that occurred around the time of implantation in addition to those that occurred after ultrasonography.

As common as nausea and vomiting are in the first trimester, researchers and clinicians should be cautious about deeming it to have a protective effect against pregnancy loss. Although such a designation may provide reassurance to some women, they should not be discouraged from seeking treatment for a condition that can have a considerable negative effect on their quality of life.

Siripanth Nippita, MD, and Laura E. Dodge, ScD, are with the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center, Boston. These comments are adapted from an accompanying editorial (JAMA Intern Med. 2016 Sep 26. doi: 10.1001/jamainternmed.2016.6101). They reported having no financial disclosures.


 

FROM JAMA INTERNAL MEDICINE

Nausea and vomiting in early pregnancy were associated with a substantially reduced risk of pregnancy loss in a prospective preconception cohort of almost 800 pregnant women.

Although there has long been the suggestion that nausea is a sign of a healthy pregnancy, the evidence supporting this idea has been limited.

“Much of the published literature reports on studies that enrolled women after a clinically recognized pregnancy, thereby failing to include women with early pregnancy losses or relying on participant recall of nausea and/or loss,” wrote Stefanie N. Hinkle, PhD, of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Md., and her colleagues.

©monkeybusinessimages/thinkstockphotos.com

In this study, the researchers examined data from 797 women with one or two prior pregnancy losses and a current pregnancy confirmed by an HCG pregnancy test. They all were enrolled in a randomized clinical trial on the effects of aspirin on gestation and reproduction (JAMA Intern Med. 2016 Sep 26. doi: 10.1001/jamainternmed.2016.5641).

Participants kept a daily record of nausea and vomiting symptoms for gestational weeks 2-8 and then monthly after that. At week 12, 86% of the women reported nausea and 35% reported nausea with vomiting at least once a week in the previous 4 weeks.

Overall, women with nausea and vomiting in any given week had a 75% lower risk of pregnancy loss during that week (hazard ratio, 0.25), while those with only nausea had a 50% reduction in pregnancy loss (HR, 0.50), compared with women with neither symptom.

For women who had a peri-implantation pregnancy loss, the researchers found a similar association but it did not reach statistical significance. The hazard ratio was 0.59 for women who had nausea only and 0.51 for women who experienced nausea with vomiting.

Among women who did not experience a peri-implantation pregnancy loss, nausea only and nausea with vomiting were associated with a 66% (HR, 0.44) and 80% (HR, 0.20) reduction in risk for pregnancy loss, respectively, compared with women with neither symptom. These reductions in risk were similar when the analysis was limited to first-trimester pregnancy loss and persisted even after accounting for lifestyle and fetal factors, such as number of prior pregnancy losses, body-mass index, fetal karyotype, and multiple fetal gestations.

“These findings overcome prior analytic and design limitations and represent the most definitive data available, to our knowledge, indicating the protective association of nausea and vomiting in early pregnancy on the risk for pregnancy loss and thus may provide reassurance to women experiencing these difficult symptoms in pregnancy,” researchers wrote.

The study was supported by the National Institutes of Health. The researchers reported having no financial disclosures.

Recommended Reading

Study reinforced value of preconception IBD care
MDedge ObGyn
Another 199 pregnant women with Zika
MDedge ObGyn
Another infant with Zika-related birth defect born in the United States
MDedge ObGyn
Doctors urge Congress to pass Zika funding
MDedge ObGyn
Meta-analysis suggests earlier twin delivery to prevent stillbirth
MDedge ObGyn
Both prepregnancy and gestational diabetes bode ill for babies
MDedge ObGyn
Case-control study points to Zika virus as cause of microcephaly
MDedge ObGyn
Number of Zika-infected pregnancies jumps in states/D.C.
MDedge ObGyn
Obstetric VTE safety recommendations stress routine risk assessment
MDedge ObGyn
Zika cases in pregnant women hit new weekly high
MDedge ObGyn